Levels of proteins C and S do not decline subsequent to first line chemotherapy in lymphoma patients

Hematological Oncology

Volumn 15, Issue 3, 1997, Pages 121-127

  Bairey, Osnat ^a,b   Gabbay, Uri ^a   Blickstein, Dorit ^a   Stark, Pinhas ^a   Prokocimer, Miron ^a   Epstein, Orit ^a   Shaklai, Mati ^a   Lahav, Judith ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b RABIN MEDICAL CENTER   (Israel)

Author keywords

Chemotherapy; Hodgkin's disease; non Hodgkin's lymphoma; Protein C; Protein S

Indexed keywords

ANTINEOPLASTIC AGENT; ANTITHROMBIN III; BLEOMYCIN; CHLORMETHINE; CYCLOPHOSPHAMIDE; CYTOTOXIC AGENT; DOXORUBICIN; ETOPOSIDE; METHOTREXATE; MITOXANTRONE; PREDNISONE; PROCARBAZINE; PROTEIN C; PROTEIN S; VINBLASTINE; VINCRISTINE;

ADOLESCENT; ADULT; AGED; ARTICLE; BREAST CANCER; CANCER COMBINATION CHEMOTHERAPY; CLINICAL ARTICLE; FEMALE; HODGKIN DISEASE; HUMAN; MALE; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; PROTEIN DETERMINATION; TREATMENT OUTCOME;

EID: 0031420756     PISSN: 02780232     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-1069(199708)15:3<121::AID-HON606>3.0.CO;2-D     Document Type: Article

References (26)

1. Donati, M. B. Cancer and thrombosis. Thromb. Haemost. 74, 278-281.
2. Sack, G. H., Levin, J., Bell, W. R. Trousseau's syndrome and other manifestations of chronic disseminated coagulopathy in patients with neoplasms: clinical, pathophysiologic and therapeutic features. Medicine 1997, 56, 1-37.
3. Ambrus, J. L., Ambrus, C. M., Mink, I. B., et al. Causes of death in cancer patients. J. Med. 1975, 6, 61-64.
4. Edwards, R. L., Rickles, F. R. Role of procoagulant activity in neoplastic disease. In: Levy, G. A., Cole, E., eds. Procoagulant Activity in Health and Disease, Florida: CRC Press, 1994: 153-176.
5. Goad, K. E., Gralnick, H. R. Coagulation disorders in cancer. Hematol. Oncol. Clinics North Am. 1996, 2, 547-583.
6. Rickles, F. R., Edwards, R. L., Barb, C., et al. Abnormalities of blood coagulation in patients with cancer. Cancer 1983, 51, 301-307.
7. Sun, N. C., McAfee, W. M., Hum, G. J., et al. Hemostatic abnormalities in malignancy, a prospective study in one hundred eight patients. I. Coagulation studies. Am. J. Clin. Pathol. 1979, 71, 10-16.
8. Edwards, R. L., Rickels, F. R., Moritz, T. E., et al. Abnormalities of blood coagulation tests in patients with cancer. Am. J. Clin. Pathol. 1987, 88, 596-602.
9. Murray J. C. Coagulation and cancer. Br. J. Cancer 1991, 64, 422-424.
10. Weiss, R. B., Tormey, D. C., Holland, J. F., et al. Venous thrombosis during multimodal treatment of primary breast carcinoma. Cancer Treat. Rep. 1981, 65, 677-679.
11. Goodnough, L. T., Saito, H., Manni, A., et al. Increased incidence of thromboembolism in stage IV breast cancer patients treated with a five drug chemotherapy regimen. Cancer 1984, 54, 1264-1268.
12. Levine, M. N., Gent, M., Hirsh, J., et al. The thrombogenic effect of anticancer drug therapy in women with stage II breast cancer. N. Engl. J. Med. 1988, 318, 404-407.
13. Feffer, S. E., Carmosino, L. S., Fox, R. L. Acquired protein C deficiency in patients with breast cancer receiving cyclophosphamide, methotrexate and 5-fluorouracil. Cancer 1989, 63, 1303-1307.
14. Rogers, J. S., Murgo, A. J., Fontana, J., et al. Chemotherapy for breast cancer decreases plasma protein C and protein S. J. Clin. Oncol. 1988, 6, 276-281.
15. Seifter, E. J., Young, R. C., Longo, D. L. Deep venous thrombosis during therapy for Hodgkin's disease. Cancer Treat. Rep. 1985, 69, 1011-1013.
16. Cantwell, B. M., Carmichael, J., Ghani, S. E., et al. Thromboses and thromboemboli in patients with lymphoma during cytotoxic chemotherapy. BMJ 1988, 297, 179-180.
17. Clarke, C. S., Otridge, B. W., Carney, D. N. Thromboembolism - a complication of weekly chemotherapy in the treatment of non-Hodgkin's lymphoma. Cancer 1990, 66, 2027-2030.
18. Ottinger, H., Belka, C., Kozole, G., et al. Deep venous thrombosis and pulmonary artery embolism in high-grade non Hodgkin's lymphoma: incidence, causes and prognostic relevance. Eur. J. Haematol. 1995, 54, 186-194.
19. Dvorak, H. F. Thrombosis and cancer. Hum. Pathol. 1987, 18, 275-284.
20. Edwards, R. L., Silver, J., Rickles, F. R. Human tumor procoagulants: registry of the subcommittee on haemostasis and malignancy of the scientific and standardization committee, international society on thrombosis and haemostasis. Thromb. Haemost. 1993, 69, 205-213.
21. Rodegheiro, F., Mannucci, P. M., Vigano, S., et al. Liver dysfunction rather than intravascular coagulation as the main cause of low protein C and antithrombin III in acute leukemia. Blood 1984, 63, 965-969.
22. Kaufman, P. A., Jones, R. B., Greenberg, C. S., et al. Autologous bone marrow transplantation and factor XII, factor VII and protein C deficiencies. Cancer 1991, 66, 515-521.
23. Zurbon, K. H., Gram, J., Glander, K., et al. Influence of cytostatic treatment on the coagulation system and fibrinolysis in patients with non-Hodgkin's lymphoma and acute leukemia. Eur. J. Haematol. 1991, 47, 55-59.
24. Gordon, B., Haire, W., Kessinger, A., et al. High frequency of antithrombin 3 and protein C deficiency following autologous bone marrow transplantation for lymphoma. Bone Marrow Transpl. 1991, 8, 497-502.
25. Harper, P. L., Jarvis, J., Jennings, I., et al. Changes in the natural anticoagulants following bone marrow transplantation. Bone Marrow Transpl. 1990, 5, 39-42.
26. Catani, L., Gugliotta, L., Mattioli Belmonte, M., et al. Hypercoagulability in patients undergoing autologous or allogeneic BMT for hematological malignancies. Bone Marrow Transpl. 1993, 12, 253-259.